Figures
Abstract
Aims
The local concentration of extracellular Ca2+ ([Ca2+]o) in bone microenvironment is accumulated during bone remodeling. In the present study we investigated whether elevating [Ca2+]o induced store-operated calcium entry (SOCE) in primary rat calvarial osteoblasts and further examined the contribution of elevating [Ca2+]o to osteoblastic proliferation.
Methods
Cytosolic Ca2+ concentration ([Ca2+]c) of primary cultured rat osteoblasts was detected by fluorescence imaging using calcium-sensitive probe fura-2/AM. Osteoblastic proliferation was estimated by cell counting, MTS assay and ATP assay. Agonists and antagonists of calcium-sensing receptors (CaSR) as well as inhibitors of phospholipase C (PLC), SOCE and voltage-gated calcium (Cav) channels were applied to study the mechanism in detail.
Results
Our data showed that elevating [Ca2+]o evoked a sustained increase of [Ca2+]c in a dose-dependent manner. This [Ca2+]c increase was blocked by TMB-8 (Ca2+ release inhibitor), 2-APB and BTP-2 (both SOCE blockers), respectively, whereas not affected by Cav channels blockers nifedipine and verapamil. Furthermore, NPS2143 (a CaSR antagonist) or U73122 (a PLC inhibitor) strongly reduced the [Ca2+]o-induced [Ca2+]c increase. The similar responses were observed when cells were stimulated with CaSR agonist spermine. These data indicated that elevating [Ca2+]o resulted in SOCE depending on the activation of CaSR and PLC in osteoblasts. In addition, high [Ca2+]o significantly promoted osteoblastic proliferation, which was notably reversed by BAPTA-AM (an intracellular calcium chelator), 2-APB, BTP-2, TMB-8, NPS2143 and U73122, respectively, but not affected by Cav channels antagonists.
Citation: Hu F, Pan L, Zhang K, Xing F, Wang X, Lee I, et al. (2014) Elevation of Extracellular Ca2+ Induces Store-Operated Calcium Entry via Calcium-Sensing Receptors: A Pathway Contributes to the Proliferation of Osteoblasts. PLoS ONE 9(9): e107217. https://doi.org/10.1371/journal.pone.0107217
Editor: João Costa-Rodrigues, Faculdade de Medicina Dentária, Universidade do Porto, Portugal
Received: March 13, 2014; Accepted: August 10, 2014; Published: September 25, 2014
Copyright: © 2014 Hu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are within the paper and its Supporting Information files.
Funding: This work was supported by the National Natural Science Foundation of China (No. 11204142), the National Basic Research Program of China (No. 2010CB934101), International S&T cooperation program of China (2011DFA52870), the 111 Project (No. B07013), the National Natural Science Foundation of China (No. 11074133, No. 31160370) and the National Science Fund for Talent Training in Basic Sciences (No. J1103208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Bone is constantly remodeling and maintaining homeostasis between formation and resorption. Reducing formation or increasing resorption may lead to bone loss, osteoporosis, eventually debilitating fractures [1]–[3]. Osteoblasts play a pivotal role in bone formation and mineralization by secreting bone matrix components and providing factors essential for osteoclast differentiation [4]–[6]. In the bone microenvironment, the resorptive action of osteoclasts results in a local increase of extracellular calcium concentration ([Ca2+]o) which can reach levels as high as 40 mM [7]. This high level of [Ca2+]o has been suggested to regulate bone formation by stimulating osteoblastic proliferation, chemotaxis, differentiation and mineralization [8]–[10]. Indeed, in vitro studies showed that high [Ca2+]o promoted proliferation in a number of osteoblast cell lines including rat calvarial osteoblasts [10].
In various cell types, the store operated calcium entry (SOCE) determines sustained cytosolic calcium concentration ([Ca2+]c) increase which is critical in regulating a variety of cellular functions including secretion, apoptosis, and more specifically proliferation [11]–[14]. SOCE is activated in response to a reduction of Ca2+ concentration in the intracellular endoplasmic reticulum (ER) stores. Under physiological conditions, receptor-mediated activation of the phospholipase C (PLC) induces the generation of inositol 1,4,5-trisphosphate (IP3) and subsequently triggers IP3 receptor-related Ca2+ release from ER, which may stimulate SOCE in turn [15]. The SOCE phenomenon was described in some osteoblast-like cells by previous studies [16]–[18]. Furthermore, it found that SOCE initiated by the stimulus of platelet-derived growth factor was involved in the proliferation of osteoblast-like MG-63 cells [18]. With respect to high [Ca2+]o-induced osteoblastic proliferation, the underlying intracellular signaling is largely unclear. Especially, it remains unknown whether the elevation of [Ca2+]o can induce SOCE, and whether high [Ca2+]o-induced osteoblastic proliferation is conducted through SOCE in osteoblasts.
It was established that extracellular Ca2+ could activate the calcium-sensing receptors (CaSR), a member of G-protein coupled receptor family [19]. The activation of CaSR mediated intracellular Ca2+ release through PLC/IP3 pathway [19]–[21]. Functional expression of CaSR had been detected in different types of osteoblast-like cells including primary rat calvarial osteoblasts [22]–[28]. Studies so far suggested that CaSR was essential for osteoblast growth, differentiation and mineralization [23]–[27], therefore played a critical role in regulation of bone development and remodeling [28], [29]. However, the downstream signal pathway mediated by CaSR has not been extensively addressed. Interestingly, CaSR-induced Ca2+ release could trigger SOCE in breast cancer cells and cardiomyocytes [30], [31], whereas did not cause Ca2+ influx in renal collecting duct cells [32]. To our knowledge, whether CaSR activation can induce SOCE in osteoblasts is still unknown. In the present work, it was found that elevating [Ca2+]o obviously induced a sustained rise of [Ca2+]c in rat calvarial osteoblasts. Therefore, the aim of this study was to investigate the mechanism of [Ca2+]c increase induced by [Ca2+]o in rat calvarial osteoblasts. We asked whether the effects of [Ca2+]o on [Ca2+]c depended on the activation of CaSR-related PLC/IP3 signaling and SOCE. Furthermore, we examined the contribution of [Ca2+]c increase to high [Ca2+]o-induced proliferation in primary rat calvarial osteoblasts.
Materials and Methods
Ethics Statement
The animal protocol in this study conformed to the Guide for the Care and Use of Laboratory Animals (the Guide, NRC 2011), and it was also approved by the Institutional Animal Care and Use Committee at Nankai University (Approval ID 201009080081).
Animals and reagents
New born Wistar rats (3-day-old) were obtained from Academy of Military Medical Sciences (Tianjin, China). DMEM and fetal bovine serum (FBS) were from Gibco (USA) and HyClone (USA), respectively. Fura-2/AM was purchased from Biotium (USA). The rest of reagents, including trypsin, collagenase II, EGTA, DMSO, thapsigargin (TG), BAPTA-AM, TMB-8, 2-APB, BTP-2 (YM-58483), U73122, U73343, NPS2143, spermine, nifedipine and verapamil were purchased from Sigma-Aldrich (USA). CellTiter 96 AQueous One Solution Cell Proliferation Assay kit and CellTiter-Glo Luminescent Cell Viability Assay kit were purchased from Promega (USA).
Osteoblasts isolation and culture
Rat calvarial osteoblasts were isolated and cultured as previously described [33], [34]. Briefly, anesthetized new born Wistar rats (3-day-old) were sacrificed by decapitation. Then, bone skulls were isolated from the soft tissue, and digested with collagenase. Calvarial cells were released by repeated digestion with trypsin. The isolated osteoblasts were cultured in DMEM medium containing 10% FBS at 37°C with 5% CO2.
Measurement of cytosolic Ca2+ concentrations ([Ca2+]c)
Osteoblasts were loaded with 5 µM fura-2/AM in Hanks’ balanced salt solution (HBSS) (NaCl 150 mM, KCl 5.4 mM, CaCl2 2 mM, MgCl2 1 mM, glucose 10 mM and HEPES 10 mM, pH = 7.4) for 1 h at room temperature. After washing extensively with HBSS, cells were bathed in fresh HBSS solution. [Ca2+]c was measured with calcium imaging system built on an inverted fluorescence microscope (Olympus IX51). The Ca2+ indicator fura-2 was alternately excited at 340 nm and 380 nm with a Lambda 10–2 sutter. Fluorescence images (filtered at 515 nm±25 nm) were captured by a CCD camera (CoolSNAP fx-M) and quantitated with MetaFluor. [Ca2+]c was represented by the ratio of fluorescence intensity at 340 nm/fluorescence intensity at 380 nm (F340/F380). At least three independent experiments were done for each condition. One curve of calcium changes was plotted as the representation of other similar traces. Ca2+-free HBSS solution was made by substituting MgCl2 for CaCl2 at the same concentration.
Proliferation Assay
The proliferation of osteoblasts was assessed by morphological observations and direct cell counting. The number of viable cells in proliferation was further determined by MTS assay (CellTiter 96 AQueous One Solution Cell Proliferation Assay kit) and ATP assay (CellTiter-Glo Luminescent Cell Viability Assay kit), respectively. For morphological observations, osteoblasts were plated in 35 mm culture dishes (∼5×104 cells/dish) with DMEM containing 5% FBS at 37°C. Then, the pretreated-cells in each dish were monitored by an inverted light microscope (Olympus IX51) at 0, 24, 48 and 72 h in turn. In the meantime, the cell numbers in each dish were measured from at least five regions (1 mm×1 mm grids) at the indicated time. For MTS and ATP assays, osteoblasts were seeded into 96-well plate at ∼1×104 cells/well at 37°C in DMEM with 5% FBS and incubated overnight before treating with or without test agents for 72 h. The MTS assay was performed by directly adding 20 µl of the AQueous One Solution Reagent to culture wells (100 µl/well), incubating for 4 h and then recording the absorbance at 490 nm (A490) with an ELISA reader (Bio-Rad Imark Microplate Reader). The ATP assay was carried out by adding 100 µl of the CellTiter-Glo Reagent (Buffer plus Substrate) to each well, then mixing contents for 2 minutes on an orbital shaker to induce cell lysis. After that the plate was incubated for 10 minutes to stabilize luminescent signal. The luminescent signal was measured by a luminometer (GloMax Multi Jr Detection System, Promega, USA). The ATP concentration in each well was derived from the standard curve.
Statistical analysis
All data passed the normality test and were presented as mean ± standard deviation. The statistical comparison between two groups was carried out using Student’s t-test (Origin 8.0), and the analysis for multiple groups was using Dunnett’s test (SPSS 18.0, one-way ANOVA). P<0.05 was considered to be statistically significant. The values of half maximal effective concentration (EC50) were calculated according to the dose-response curve fitting with the logistic equation: , where Y is the response, Ymax is the asymptotic maximum, Ymin is the asymptotic minimum, x is the extracellular calcium concentration and n is the Hill coefficient.
Results
Thapsigargin induced SOCE in rat calvarial osteoblasts
Firstly, we checked the ability of generating SOCE in rat calvarial osteoblasts with ER Ca2+-pump blocker thapsigargin (TG), a drug widely used to test SOCE. It was seen from Figure 1A that the application of TG (1 µM) evoked a transient [Ca2+]c rise mediated by Ca2+ release from Ca2+ stores with nominally Ca2+-free HBSS. Adding 2 mM CaCl2 after [Ca2+]c returning to the basal level triggered [Ca2+]c increase due to Ca2+ entry. This Ca2+ entry was strongly inhibited by the application of potent SOCE blockers 2-APB (25 µM) [35], [36] (value of F340/F380: 0.50±0.04 before application of 2-APB vs. 0.30±0.02 after application of 2-APB for 100 s, P<0.05) or BTP-2 (YM-58483, 20 µM) [37] (value of F340/F380: 0.51±0.07 before application of BTP-2 vs. 0.38±0.10 after application of BTP-2 for 100 s, P<0.05) during the high [Ca2+]c plateau evoked by adding 2 mM CaCl2 (Figure 1C–F). In addition, Ca2+ entry was evidently abolished when cells were pretreatment with 2-APB (25 µM) or BTP-2 (20 µM) before adding TG (value of F340/F380 at 400 s: 0.46±0.10 for control vs. 0.35±0.05 for 2-APB vs. 0.34±0.07 for BTP-2, P<0.05; Figure 1G and H). Taken together, these data confirmed the existence of SOCE in rat calvarial osteoblasts and the efficient inhibition of 2-APB and BTP-2 on SOCE.
(A) After calcium store depletion by a calcium pump blocker TG (1 µM) in Ca2+-free buffer, addition of 2 mM external Ca2+ resulted in obvious calcium entry; then, further removal of external Ca2+ caused [Ca2+]c decrease to baseline, suggesting the putative response for SOCE. (C, E) [Ca2+]c increase was caused by TG (1 µM) in Ca2+-free HBSS, followed by application of 25 µM 2-APB or 20 µM BTP-2 during the high [Ca2+]c plateau induced by re-addition of 2 mM external Ca2+, resulting in return to baseline [Ca2+]c. Statistic data of ratio of F340/F380 before and after the application of Ca2+ free HBSS (B), 2-APB (D) and BTP-2 (F). * showed P<0.05. (G) 1 µM TG was added after pretreatment with 25 µM 2-APB or 20 µM BTP-2 for 15 min, then, further addition of 2 mM external Ca2+ had no effect on [Ca2+]c change. (H) Summary of the ratio of F340/F380 at 400 s from experiments shown in (G), * showed P<0.05.
Elevating [Ca2+]o induced increases in [Ca2+]c in rat calvarial osteoblasts
The effects of elevating [Ca2+]o on [Ca2+]c were measured by calcium imaging. A rise in F340/F380 ratio indicated an increase in [Ca2+]c. Representative [Ca2+]c profiles were shown in Figure 2A. Elevating [Ca2+]o from 0 mM to 1, 2, 3, 5, 10 and 20 mM resulted in a rapid increase in [Ca2+]c followed by a sustained high [Ca2+]c plateau. The increase of [Ca2+]c was dependent on the level of [Ca2+]o. We measured the peak value of [Ca2+]c increase and plotted it against the concentrations of extracellular Ca2+ (Figure 2B). The dose-dependent curve was fitted with an EC50 of 5.4±1.2 mM.
(A) Representative tracings of [Ca2+]c responses induced by [Ca2+]o at 0, 1, 2, 3, 5, 10 and 20 mM, respectively. (B) The statistic peak values of increase in F340/F380 ratio were plotted against [Ca2+]o (n = 15 for each case), * showed P<0.05. The smooth curve represented the fitting to the equation of with an EC50 value of 5.4±1.2 mM and Hill coefficient (n) of 2.2
Voltage-gated calcium channels did not contribute to [Ca2+]o-induced [Ca2+]c increase
Because rat calvarial osteoblasts expressed voltage-gated calcium (Cav) channels [38], [39], we tested whether Cav channels contributed to [Ca2+]o-induced [Ca2+]c increase. It found that pretreatment the cells with Cav blockers nifedipine (10 µM) [27], [40] or verapamil (10 µM) [40] had little influence on the [Ca2+]c increase evoked by elevating [Ca2+]o (10 mM) as show in Figure 3A. The peak values for [Ca2+]c increase were not different from that of control (value of increase in F340/F380 at 250 s: 0.15±0.03 for control vs. 0.14±0.01 for nifedipine vs. 0.15±0.01 for verapamil, P>0.05; Figure 3B). To verify the effectiveness of these two Cav blockers, a high [K+]o experiment was performed as positive control. Data showed that elevating [K+]o from 0 mM to 100 mM triggered a rapid increase of [Ca2+]c (black line, Figure 3C), which was known to be attributed to Ca2+ entry through Cav channels (blue line, Figure 3C). Meanwhile, both verapamil and nifedipine at the used concentrations could block this [K+]o-induced Ca2+ entry (peak value of increase in F340/F380: 0.19±0.03 for control vs. 0.042±0.006 for nifedipine vs. 0.014±0.009 for verapamil, P<0.05; Figure 3C and D). These data together indicated that Cav channels did not participate in the process of [Ca2+]o-induced [Ca2+]c increase.
(A) Representative tracings of [Ca2+]c changes caused by elevating [Ca2+]o (10 mM) alone (control) and in the presence of nifedipine (10 µM) or verapamil (10 µM). Nifedipine or verapamil was added for 15 min before elevating [Ca2+]o. (B) Summary of the changes in F340/F380 at 250 s after the elevation of [Ca2+]o from experiments shown in (A). (C) Typical tracings of [Ca2+]c changes caused by elevating [K+]o (100 mM) alone (control) and in the presence of Ca2+ free HBSS, nifedipine (10 µM) or verapamil (10 µM). Nifedipine or verapamil was added for 15 min before elevating [K+]o. (D) Summary of the peak values of increase in F340/F380 after the elevation of [K+]o from experiments shown in (C).
SOCE played key roles in the [Ca2+]c increase induced by elevating [Ca2+]o
To investigate whether SOCE was associate with [Ca2+]o-induced [Ca2+]c increase, a series of experiments were carried out. Firstly, the rise of [Ca2+]c induced by 10 mM [Ca2+]o was decreased significantly (value of increase in F340/F380 at 250 s: 0.15±0.03 for control vs. 0.03±0.01 for TMB-8 vs. 0.04±0.01 for 2-APB vs. 0.03±0.01 for BTP-2, P<0.05; Figure 4A and B) when cells were pretreated with 50 µM TMB-8 (a calcium release inhibitor) [41], 25 µM 2-APB and 20 µM BTP-2, respectively. Secondly, substitution with Ca2+ free HBSS during the [Ca2+]o-induced high [Ca2+]c plateau rapidly reduced [Ca2+]c to the baseline, indicating the sustained high [Ca2+]c plateau was attributed to Ca2+ entry (value of F340/F380: 0.42±0.08 before removal of 10 mM [Ca2+]o vs. 0.29±0.01 after removal of 10 mM [Ca2+]o for 100 s, P<0.05; Figure 4C and D). Similar responses were observed after the application of 25 µM 2-APB (value of F340/F380: 0.42±0.07 before application of 2-APB vs. 0.28±0.06 after application of 2-APB for 100 s, P<0.05) or 20 µM BTP-2 (value of F340/F380: 0.42±0.06 before application of BTP-2 vs. 0.26±0.07 after application of BTP-2 for 100 s, P<0.05) (Figure 4E–H). Taken together, these results above revealed that elevating [Ca2+]o induced the activation of SOCE underlying the increase of [Ca2+]c.
(A) Typical tracings of [Ca2+]c responses resulted from elevating [Ca2+]o (10 mM) in the absence (control) and in the presence of 2-APB (25 µM), BTP-2 (20 µM), or TMB-8 (50 µM). Such reagents were added for 15 min before the elevation of [Ca2+]o. (B) Summary of the changes in F340/F380 at 250 s after the elevation of [Ca2+]o from experiments shown in (A), * showed P<0.05 comparing with control. (C, E, G) Representative tracings showing the effects of application of Ca2+ free HBSS, 25 µM 2-APB or 20 µM BTP-2 on the high [Ca2+]c plateau induced by elevating [Ca2+]o. Statistic data of the ratio of F340/F380 before and after the application of Ca2+ free HBSS (D), 2-APB (F) and BTP-2 (H), * showed P<0.05.
[Ca2+]o-induced SOCE was dependent on the activation of CaSR
The role of CaSR-PLC/IP3 signaling in [Ca2+]o-induced SOCE was examined in the following experiments. Firstly, the elevating [Ca2+]o-induced [Ca2+]c increase was almost abolished when cells were pretreated with a specific CaSR antagonist NPS2143 (10 µM) [27] (value of increase in F340/F380 at 250 s: 0.14±0.02 for control vs. 0.024±0.004 for NPS2143, P<0.05; Figure 5A and B), suggesting the contribution of CaSR to SOCE. Moreover, U73122 (5 µM) [36], [42], a potent PLC inhibitor, attenuated the [Ca2+]c rise significantly (value of increase in F340/F380 at 250 s: 0.14±0.02 for control vs. 0.03±0.02 for U73122, P<0.05; Figure 5A and B), indicating the involvement of PLC. In addition, we tested the effects of spermine, a polycationic agonist of CaSR, taking it as a positive control. It can be seen from Figure 5C–E, spermine (2 mM) triggered [Ca2+]c increase with similar characteristics to that of [Ca2+]c change resulted from elevated [Ca2+]o. As expected, the removal of extracellular calcium or pretreatment with 2-APB (25 µM) and BTP-2 (20 µM) suppressed the sustained [Ca2+]c increase induced by spermine in Ca2+-containing HBSS (Figure 5C and E). It also failed to evoke a [Ca2+]c increase by spermine in the presence of NPS2143 (10 µM) or U73122 (5 µM) (Figure 5D and E) in Ca2+-containing buffer. In contrast, U73343, an inactive analog of U73122, had little effect on the [Ca2+]c increase induced by either [Ca2+]o (value of increase in F340/F380 at 250 s: 0.14±0.02 for control vs. 0.11±0.03 for U73343, P>0.05; Figure 4A and B) or spermine (value of increase in F340/F380 at 400 s: 0.11±0.01 for control vs. 0.10±0.01 for U73343, P>0.05; Figure 5D and E). Taken together, these data suggested an essential role for CaSR activation and the subsequent PLC-IP3 pathway in [Ca2+]o elevation-induced SOCE.
(A) Representative tracings of [Ca2+]c changes induced by elevating [Ca2+]o (10 mM) alone (control) and in the presence of NPS2143 (10 µM), U73122 (5 µM) or U73343 (5 µM). Such reagents were added 15 min before application of the elevation of [Ca2+]o. (B) Summary of the changes in F340/F380 at 250 s after the elevation of [Ca2+]o from experiments shown in (A), * showed P<0.05, compared with control in each group. (C) Typical tracings of [Ca2+]c responses induced by induced by 2 mM spermine in the presence (black) and absence (red) of external Ca2+. Cells were pretreated with 25 µM 2-APB (blue) or 20 µM BTP-2 (purple) for 15 min prior to spermine (2 mM) in Ca2+-containing HBSS. (D) Representative tracings of [Ca2+]c changes in response to 2 mM spermine in the presence of NPS2143 (10 µM), U73122 (5 µM) or U73343 (5 µM) in Ca2+-containging HBSS. Such reagents were added 15 min before adding spermine. (E) Summary of the changes in F340/F380 at 400 s after the stimulation with spermine in the presence Ca2+ free HBSS, 2-APB, BTP-2, NPS2143, U73122 or U73343 from experiments shown in C and D, * showed P<0.05 comparing with control (spermine alone) in each group.
SOCE was involved in the high [Ca2+]o-induced proliferation
To investigate the effects of [Ca2+]o on the proliferation capacity of osteoblasts and the contribution of [Ca2+]o-induced [Ca2+]c increase to proliferation of osteoblasts, we carried out a series of experiments to assess the cell proliferation in different levels of [Ca2+]o with or without various inhibitors by morphological observations and cell counting, as well as estimating the proliferating activity by MTS and ATP assays. Morphological images of osteoblasts were obtained with medium containing 1.8, 3, 5, 10 mM [Ca2+]o at 0, 24, 48 and 72 h, respectively. It was found that the cell numbers in medium with higher [Ca2+]o were increased significantly in comparison with control (normal DMEM medium, [Ca2+]o = 1.8 mM) in a concentration-dependent and time-dependent manner (Figure 6A and B). Meanwhile, the absorbance (A490) (MTS assay) (Figure 6C) and ATP concentration (ATP assay) (Figure S1) were increased with higher [Ca2+]o medium at 72 h. In addition, this increase of proliferation induced by 10 mM [Ca2+]o was completely blocked by an intracellular calcium chelator BAPTA-AM (2 µM) (Figure 6A–C and Figure S1). Furthermore, 10 mM [Ca2+]o-stimulated cell proliferation was decreased significantly in the presence of 2-APB (25 µM), BTP-2 (20 µM), TMB-8 (50 µM), NPS2143 (10 µM) and U73122 (5 µM), respectively, while treating osteoblasts with U73343 (5 µM), nifedipine (10 µM) or verapamil (10 µM) had little influence on cell proliferation (Figure 6D and E, Figure S1 and S2). These data indicated that the CaSR activation-induced SOCE participated in the process of high [Ca2+]o-promoted cell proliferation in rat calvarial osteoblasts.
(A) Osteoblasts were cultured in medium containing different levels of [Ca2+]o or in a medium with 2 µM BAPTA-AM+10 mM [Ca2+]o. Typical cell morphological images were captured at 0 h, 24 h and 48 h and 72 h using a 10× objective. (B) Statistic data of cell numbers from experiments shown in (A). Each group of cells were grown in triplicate dishes and counted at different time points by measuring at least five regions (1 mm×1 mm grids). *P<0.05, compared with control group (normal DMEM medium); # P<0.05, compared with 10 mM [Ca2+]o group. (C) Summary of absorbance (A490) in each group. Absorbance (A490) assessed by MTS assay is proportional to the number of living cells. Osteoblasts were incubated for 72 h in culturing medium with different levels of [Ca2+]o or in a medium with 2 µM BAPTA-AM+10 mM [Ca2+]o (n = 7 for each case), * showed P<0.05, compared with [Ca2+]o = 1.8 mM group; # showed P<0.05, compared with [Ca2+]o = 10 mM group. (D) Statistic data of cell numbers in each group at different time points. Osteoblasts were cultured in medium containing 10 mM [Ca2+]o alone or together with 2-APB (25 µM), BTP-2 (20 µM), TMB-8 (50 µM), NPS2143 (10 µM), U73122 (5 µM), U73343 (5 µM), nifedipine (10 µM) and verapamil (10 µM), respectively. * showed P<0.05 in comparison with [Ca2+]o = 10 mM group. (E) Summary of absorbance (A490) measured after culturing for 72 h in [Ca2+]o = 10 mM medium alone or 2-APB (25 µM), BTP-2 (20 µM), TMB-8 (50 µM), NPS2143 (10 µM), U73122 (5 µM), U73343 (5 µM), nifedipine (10 µM) and verapamil (10 µM) (n = 7 for each case), respectively. * showed P<0.05 compared with [Ca2+]o = 10 mM group.
Discussion
In the present study, we found that elevating [Ca2+]o triggered [Ca2+]c increases in a dose-dependent manner with a EC50 of 5.4±1.2 mM in rat calvarial osteoblasts. This [Ca2+]c increase was abolished by SOCE blockers 2-APB and BTP-2, or Ca2+ release inhibitor TMB-8, while not affected by Cav channels antagonists nifedipine or verapamil. Furthermore, specific CaSR antagonist NPS2143 or PLC inhibitor U73122 strongly reduced the [Ca2+]c increase resulted from elevating [Ca2+]o. These data indicated that elevating [Ca2+]o induced SOCE in osteoblasts, which was dependent on the activation of CaSR and PLC. The SOCE route, rather than Cav channels contributed to elevation [Ca2+]o-induced [Ca2+]c increase. In addition, high levels of [Ca2+]o promoted the proliferation of osteoblasts. This promotion was also significantly inhibited by 2-APB, BTP-2, TMB-8, NPS2143 and U73122, respectively, suggesting a contribution of CaSR-related PLC/IP3-SOCE pathway to high [Ca2+]o-induced proliferation in osteoblasts.
The local concentration of extracellular Ca2+ in bone microenvironment is fluctuant during bone remodeling, and it regulates the functions of osteoblasts including proliferation. However, the intracellular signaling activated by extracellular Ca2+ in osteoblasts is largely unknown. The most significant finding of this study was that we found elevation of extracellular Ca2+ concentration induced SOCE by triggering the activation of CaSR and PLC. Firstly, we demonstrated that elevated [Ca2+]o triggered a sustained [Ca2+]c increase (Figure 2A). This [Ca2+]c increase played key roles in cell proliferation (Figure 6B; experiment with BAPTA-AM). We further showed that extracellular Ca2+ entry contributed mostly to the sustained [Ca2+]c increase (Figure 4C). In most cell types, SOCE mediated extracellular Ca2+ entry for ER Ca2+ store refilling [11], and more importantly, the SOCE phenomenon was found in several osteoblastic cell lines including rat calvarial osteoblasts [16]–[18]. On the other hand, some papers reported the functional expression of Cav channels in osteoblasts, which regulated the cell proliferation and differentiation dependent on the type and expression level of Cav channels [38], [39]. Thus, Cav channels may also serve as candidate channels accounting for Ca2+ capacitive entry. We addressed these two presumptions in this study. Our data showed that SOCE blockers 2-APB, BTP-2, or Ca2+ release inhibitor TMB-8 almost abolished the [Ca2+]o-triggered [Ca2+]c increase (Figure 4), whereas Cav channels antagonists had little effects (Figure 3). These results suggested that [Ca2+]o-induced [Ca2+]c increase was most likely through the activation of SOCE route rather than Cav channels. With respect to the molecular components of SOCE conducting Ca2+ entry, some transient receptor potential (TRP) channels especially TRPC subfamily were considered for candidate SOCE machinery in osteoblasts as well as other cell types. Many members of TRP channels had been identified to exist in osteoblasts and served as SOCE machinery [43]–[45]. For instance, reports showed that the TRPC1 channel played a key role in SOCE and cell proliferation induced by platelet-derived growth factor in osteoblast-like MG-63 cell line [18], while TRPC3 was related to vitamin D-induced SOCE in chick skeletal muscle [46] and ROS 17/2.8 rat osteoblastic cells [47]. However, which member of TRPC channels actually contributed to elevated [Ca2+]o-triggered [Ca2+]i increases needs further investigation.
In terms of how extracellular Ca2+ activated SOCE, it was known that extracellular Ca2+ could stimulate G protein-PLC pathway by activating CaSR in various cell types. Then the following production of IP3 caused Ca2+ release. Functional CaSR was expressed in different types of osteoblast-like cells including primary rat calvarial osteoblasts [22]–[28]. However, it is not clear whether CaSR activation can cause SOCE in osteoblasts. In the present study, we found that elevated [Ca2+]o-induced [Ca2+]c increase was strongly blocked by specific CaSR antagonist NPS2143 and PLC inhibitor U73122. Similar responses were observed when the cells were stimulated with spermine, a specific CaSR agonist (Figure 5). Furthermore, the EC50 value for [Ca2+]o-induced [Ca2+]c increase was 5.4 mM, which was close to the EC50 value of CaSR in response to extracelluar Ca2+ [19]. These data together indicated that extracellular Ca2+-induced SOCE was dependent on the activation of CaSR-related PLC/IP3 pathway.
Another interesting finding of the present study was that we demonstrated the contribution of SOCE and CaSR-related PLC/IP3 signaling in high [Ca2+]o-induced proliferation in primary rat calvarial osteoblasts. It has been established that high level of [Ca2+]o promoted the proliferation in a number of osteoblastic cell lines. A few papers reported that multiple intracellular signal pathways such as calcium/calmodulin, MEK/ERK could be activated by high [Ca2+]o stimulation and played roles in mediating high [Ca2+]o-promoted proliferation in different types of osteoblasts [9], [10], [48]–[51]. But how activation of these signal pathways leads to osteoblastic proliferation is still unclear now. As reported, high [Ca2+]o activated PLC, probably through a G-protein-coupled receptor mechanism, which then caused accumulation of IP3 and mobilization of intracellular calcium, subsequently activated calcium/calmodulin/CaMKII signaling [9]. Furthermore, in primary human osteoblasts and MG-63 cells, high [Ca2+]o-stimulated proliferation was dependent on sustained activation of extracellular signal-regulated kinase 1 (ERK1) and ERK2, but other mitogen-activated protein (MAP) kinase signal pathways, p38 MAP kinase and SAPK/JNK, were not activated by [Ca2+]o in osteoblasts [10]. ERK pathway was also found to participate in mediating bone morphogenetic protein (BMP)-2 gene expression induced by elevated [Ca2+]o in human dental pulp cells [48]. High [Ca2+]o was required for phosphate-dependent ERK1/2 phosphorylation and regulation of mineralization-associated genes in osteoblasts [49]. Besides, other signal pathways including calcineurin/NFAT and cAMP/PKA were involved in other cell functions such as gene expression induced by high extracellular calcium [50], [51]. In addition to the above mechanisms, the route of SOCE also played an important role in proliferation by inducing sustained [Ca2+]c increase in various cell types including embryonic stem cells and smooth muscle cells [12]–[14]. Therefore, it’s necessary to concern about its role in the high [Ca2+]o-induced proliferation of osteoblasts. In this study, our data showed that intracellular calcium chelator BAPTA-AM reversed the high [Ca2+]o-induced proliferation. 2-APB, BTP-2, TMB-8, NPS2143 or U73122 also reduced the [Ca2+]o-induced proliferation (Figure 6), indicating the contribution of CaSR/PLC activation-evoked SOCE to high [Ca2+]o-induced proliferation of osteoblasts. In contrast, nifedipine or verapamil had little influence on the proliferation, suggesting that Cav channels were not involved. These results added a new insight to the current understanding on the role of extracellular calcium in osteoblasts proliferation.
In summary, we demonstrated that the elevation of [Ca2+]o could stimulate CaSR, activate PLC, then trigger SOCE and consequently result in a sustained increase of [Ca2+]c. This process was involved in osteoblastic proliferation induced by high level of extracellular Ca2+ concentration. These findings may lead to new insights in the mechanisms of osteoblastic proliferation, and could provide some cellular basis for physiological regulation of bone remodeling.
Supporting Information
Figure S1.
10 mM [Ca2+]o-induced increase in ATP concentration was blocked by inhibitors including BAPTA-AM, 2-APB, BTP-2, TMB-8, NPS2143 and U73122, but not affected by U73122 inactive analog U73343, voltage-gated calcium channels blockers nifedipine and verapamil in rat calvarial osteoblasts. (A) Statistic data of ATP concentration in each group. The quantitation of the ATP concentration assessed by ATP assay is proportional to the number of viable cells present in culture. Osteoblasts were incubated for 72 h in culturing medium with different levels of [Ca2+]o or in a medium with 2 µM BAPTA-AM+10 mM [Ca2+]o (n = 7 for each case), * showed P<0.05, compared with [Ca2+]o = 1.8 mM group; # showed P<0.05, compared with [Ca2+]o = 10 mM group. (B) Statistic data of ATP concentration measured after culturing for 72 h in [Ca2+]o = 10 mM medium alone or together with 2-APB (25 µM), BTP-2 (20 µM), TMB-8 (50 µM), NPS2143 (10 µM), U73122 (5 µM), U73343 (5 µM), nifedipine (10 µM) and verapamil (10 µM) (n = 5 for each case), respectively. * showed P<0.05 in comparison with [Ca2+]o = 10 mM group.
https://doi.org/10.1371/journal.pone.0107217.s001
(TIF)
Figure S2.
High [Ca2+]o-induced increase in cell numbers was blocked by inhibitors including 2-APB, BTP-2, TMB-8, NPS2143 and U73122, respectively, but not affected by voltage-gated calcium channels blockers nifedipine and verapamil in rat calvarial osteoblasts. Osteoblasts were cultured in medium with 10 mM [Ca2+]o alone or together with 2-APB (25 µM), BTP-2 (20 µM), TMB-8 (50 µM), NPS2143 (10 µM), U73122 (5 µM), U73343 (5 µM), nifedipine (10 µM) and verapamil (10 µM). Representative cell morphological images were captured at 0 h, 24 h, 48 h and 72 h using a 10× objective.
https://doi.org/10.1371/journal.pone.0107217.s002
(TIF)
Acknowledgments
We thank Zhaohui Zhai (Institute of Fluid Physics, China Academy of Engineering Physics) and Kun Song (Nankai University, Tianjin, China) for useful and enjoyable discussions.
Author Contributions
Conceived and designed the experiments: FH LP JX. Performed the experiments: FH LP KZ FX. Analyzed the data: FH XW IL XZ. Contributed reagents/materials/analysis tools: LP IL XZ JX. Contributed to the writing of the manuscript: FH LP IL.
References
- 1. Henriksen K, Neutzsky-Wulff AV, Bonewald LF, Karsdal MA (2009) Local communication on and within bone controls bone remodeling. Bone 44: 1026–1033.
- 2. Nakahama K (2010) Cellular communications in bone homeostasis and repair. Cell Mol Life Sci 67: 4001–4009.
- 3. Martin T, Gooi JH, Sims NA (2009) Molecular mechanisms in coupling of bone formation to resorption. Crit Rev Eukaryot Gene Expr 19: 73–88.
- 4. Mackie EJ (2003) Osteoblasts: novel roles in orchestration of skeletal architecture. Int J Biochem Cell Biol 35: 1301–1305.
- 5. Raggatt LJ, Partridge NC (2010) Cellular and molecular mechanisms of bone remodeling. J Biol Chem 285: 25103–25108.
- 6. Matsuo K, Irie N (2008) Osteoclast-osteoblast communication. Arch Biochem Biophys 473: 201–209.
- 7. Silver IA, Murrills RJ, Etherington DJ (1988) Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res 175: 266–276.
- 8. Dvorak MM, Siddiqua A, Ward DT, Carter DH, Dallas SL, et al. (2004) Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones. Proc Natl Acad Sci USA 101: 5140–5145.
- 9. Zayzafoon M (2006) Calcium/calmodulin signaling controls osteoblast growth and differentiation. J Cell Biochem 97: 56–70.
- 10. Huang Z, Cheng SL, Slatopolsky E (2001) Sustained activation of the extracellular signal-regulated kinase pathway is required for extracellular calcium stimulation of human osteoblast proliferation. J Biol Chem 276: 21351–21358.
- 11. Parekh AB, Putney JW Jr (2005) Store-operated calcium channels. Physiol Rev 85: 757–810.
- 12. Leung FP, Yung LM, Yao X, Laher I, Huang Y (2008) Store-operated calcium entry in vascular smooth muscle. Br J Pharmacol 153: 846–857.
- 13. Wong CK, So WY, Law SK, Leung FP, Yau KL, et al. (2012) Estrogen controls embryonic stem cell proliferation via store-operated calcium entry & the nuclear factor of activated T-cells (NFAT). J Cell Physiol 227: 2519–2530.
- 14. El Boustany C, Bidaux G, Enfissi A, Delcourt P, Prevarskaya N, et al. (2008) Capacitative calcium entry and transient receptor potential canonical 6 expression control human hepatoma cell proliferation. Hepatology 47: 2068–2077.
- 15. Vazquez G, Wedel BJ, Bird GS, Joseph SK, Putney JW (2002) An inositol 1,4,5-trisphosphate receptor-dependent cation entry pathway in DT40 B lymphocytes. EMBO J 21: 4531–4538.
- 16. Wiemann M, Büsselberg D, Schirrmacher K, Bingmann D (1998) A calcium release activated calcium influx in primary cultures of rat osteoblast-like cells. Calcif Tissue Int 63: 154–159.
- 17. Wiemann M, Schirrmacher K, Büsselberg D (1999) Interference of lead with the calcium release activated calcium flux of osteoblast-like cells. Calcif Tissue Int 65: 479–85.
- 18. Labelle D, Jumarie C, Moreau R (2007) Capacitative calcium entry and proliferation of human osteoblast-like MG-63 cells. Cell Prolif 40: 866–884.
- 19. Riccardi D, Finney BA, Wilkinson WJ, Kemp PJ (2009) Novel regulatory aspects of the extracellular Ca2+-sensing receptor, CaR. Pflugers Arch 458: 1007–1022.
- 20. Breitwieser GE, Gama L (2001) Calcium-sensing receptor activation induces intracellular calcium oscillations. Am J Physiol Cell Physiol 280: C1412–1421.
- 21. Rey O, Young SH, Yuan J, Slice L, Rozengurt E (2005) Amino acid-stimulated Ca2+ oscillations produced by the Ca2+-sensing receptor are mediated by a phospholipase C/inositol 1,4,5-trisphosphate-independent pathway that requires G12, Rho, filamin-A, and the actin cytoskeleton. J Biol Chem 280: 22875–22882.
- 22. Yamaguchi T, Chattopadhyay N, Kifor O, Ye C, Vassilev PM, et al. (2001) Expression of extracellular calcium-sensing receptor in human osteoblastic MG-63 cell line. Am J Physiol Cell Physiol 280: C382–C393.
- 23. Chattopadhyay N, Yano S, Tfelt-Hansen J, Rooney P, Kanuparthi D, et al. (2004) Mitogenic action of calcium-sensing receptor on rat calvarial osteoblasts. Endocrinology 145: 3451–3462.
- 24. Yamaguchi T, Chattopadhyay N, Kifor O, Butters RR Jr, Sugimoto T, et al. (1998) Mouse osteoblastic cell line (MC3T3-E1) expresses extracellular calcium (Ca2+o)-sensing receptor and its agonists stimulate chemotaxis and proliferation of MC3T3-E1 cells. J Bone Miner Res 13: 1530–1538.
- 25. Yamauchi M, Yamaguchi T, Kaji H, Sugimoto T, Chihara K (2005) Involvement of calcium-sensing receptor in osteoblastic differentiation of mouse MC3T3-E1 cells. Am J Physiol Endocrinol Metab 288: E608–616.
- 26. Takaoka S, Yamaguchi T, Yano S, Yamauchi M, Sugimoto T (2010) The Calcium-sensing Receptor (CaR) is involved in strontium ranelate-induced osteoblast differentiation and mineralization. Horm Metab Res 42: 627–631.
- 27. Koori K, Maeda H, Fujii S, Tomokiyo A, Kawachi G, et al. (2014) The roles of calcium-sensing receptor and calcium channel in osteogenic differentiation of undifferentiated periodontal ligament cells. Cell Tissue Res DOI 10.1007/s00441-014-1918-5.
- 28. Dvorak-Ewell MM, Chen TH, Liang N, Garvey C, Liu B, et al. (2011) Osteoblast extracellular Ca2+-sensing receptor regulates bone development, mineralization, and turnover. J Bone Miner Res 26: 2935–2947.
- 29. Caudarella R1, Vescini F, Buffa A, Rizzoli E, Ceccoli L, et al (2011) Role of calcium-sensing receptor in bone biology. J Endocrinol Invest 34: 13–17.
- 30. El Hiani Y, Ahidouch A, Lehen'kyi V, Hague F, Gouilleux F, et al. (2009) Extracellular signal-regulated kinases 1 and 2 and TRPC1 channels are required for calcium-sensing receptor-stimulated MCF-7 breast cancer cell proliferation. Cell Physiol Biochem 23: 335–346.
- 31. Feng SL, Sun MR, Li TT, Yin X, Xu CQ, et al. (2011) Activation of calcium-sensing receptor increases TRPC3 expression in rat cardiomyocytes. Biochem Biophys Res Commun 406: 278–284.
- 32. Valenti G, Mira A, Mastrofrancesco L, Lasorsa DR, Ranieri M, et al. (2010) Differential modulation of intracellular Ca2+ responses associated with calcium-sensing receptor activation in renal collecting duct cells. Cell Physiol Biochem 26: 901–912.
- 33. Partridge NC, Alcorn D, Michelangeli VP, Kemp BE, Ryan GB, et al. (1981) Functional properties of hormonally responsive cultured normal and malignant rat osteoblastic cells. Endocrinology 108: 213–219.
- 34. Chaudhari A, Ron E, Rethman MP (1997) Recombinant human bone morphogenetic protein-2 stimulates differentiation in primary cultures of fetal rat calvarial osteoblasts, Mol Cell Biochem. 167: 31–39.
- 35. DeHaven WI, Smyth JT, Boyles RR, Bird GS, Putney JW Jr (2008) Complex actions of 2-aminoethyldiphenyl borate on store-operated calcium entry. J Biol Chem 283: 19265–19273.
- 36. Pan L, Wu X, Zhao D, Hessari NM, Lee I, et al. (2011) Sulfhydryl modification induces calcium entry through IP3-sensitive store-operated pathway in activation-dependent human neutrophils. PLoS One 6: e25262.
- 37. Ishikawa J, Ohga K, Yoshino T, Takezawa R, Ichikawa A, et al. (2003) A pyrazole derivative, YM-58483, potently inhibits store-operated sustained Ca2+ influx and IL-2 production in T lymphocytes. J Immunol 170: 4441–4449.
- 38. Shao Y, Alicknavitch M, Farach-Carson MC (2005) Expression of voltage sensitive calcium channel (VSCC) L-type Cav1.2 (alpha1C) and T-type Cav3.2 (alpha1 H) subunits during mouse bone development. Dev Dyn 234: 54–62.
- 39. Bergh JJ, Xu Y, Farach-Carson MC (2004) Osteoprotegerin expression and secretion are regulated by calcium influx through the L-type voltage-sensitive calcium channel. Endocrinology 145: 426–436.
- 40. Hattori T, Maehashi H, Miyazawa T, Naito M (2001) Potentiation by stannous chloride of calcium entry into osteoblastic MC3T3-E1 cells through voltage-dependent L-type calcium channels. Cell Calcium 30: 67–72.
- 41. Pan L, Zhang X, Song K, Wu X, Xu J (2008) Exogenous nitric oxide-induced release of calcium from intracellular IP3 receptor-sensitive stores via S-nitrosylation in respiratory burst-dependent neutrophils. Biochem Biophys Res Commun 377: 1320–1325.
- 42. Hu F, Yang S, Zhao D, Zhu S, Wang Y, et al. (2012) Moderate extracellular acidification inhibits capsaicin-induced cell death through regulating calcium mobilization, NF-κB translocation and ROS production in synoviocytes. Biochem Biophys Res Commun 424: 196–200.
- 43. Abed E, Labelle D, Martineau C, Loghin A, Moreau R (2009) Expression of transient receptor potential (TRP) channels in human and murine osteoblast-like cells. Mol Membr Biol 26: 146–158.
- 44. Suzuki Y, Kodama D, Goto S, Togari A (2011) Involvement of TRP channels in the signal transduction of bradykinin in human osteoblasts. Biochem Biophys Res Commun 410: 317–321.
- 45. Pan L, Song K, Hu F, Sun W, Lee I (2013) Nitric oxide induces apoptosis associated with TRPV1 channel-mediated Ca2+ entry via S-nitrosylation in osteoblasts. Eur J Pharmacol 715: 280–285.
- 46. Santillán G, Baldi C, Katz S, Vazquez G, Boland R (2004) Evidence that TRPC3 is a molecular component of the 1alpha,25(OH)2D3-activated capacitative calcium entry (CCE) in muscle and osteoblast cells. J Steroid Biochem Mol Biol 89–90: 291–295.
- 47. Baldi C, Vazquez G, Calvo JC, Boland R (2003) TRPC3-like protein is involved in the capacitative cation entry induced by 1alpha,25-dihydroxy-vitamin D3 in ROS 17/2.8 osteoblastic cells. J Cell Biochem 90: 197–205.
- 48. Tada H, Nemoto E, Kanaya S, Hamaji N, Sato H, et al. (2010) Elevated extracellular calcium increases expression of bone morphogenetic protein-2 genevia a calcium channel and ERK pathway in human dental pulp cells. Biochem Biophys Res Commun 394: 1093–1097.
- 49. Khoshniat S, Bourgine A, Julien M, Petit M, Pilet P, et al. (2011) Phosphate-dependent stimulation of MGP and OPN expression in osteoblasts via the ERK1/2 pathway is modulated by calcium. Bone 48: 894–902.
- 50. Lee HL, Bae OY, Baek KH, Kwon A, Hwang HR, et al. (2011) High extracellular calcium-induced NFATc3 regulates the expression of receptor activator of NF-κB ligand in osteoblasts. Bone 49: 242–249.
- 51. Kanaya S, Nemoto E, Ebe Y, Somermanb MJ, Shimauchia CH (2010) Elevated extracellular calcium increases fibroblast growth factor-2 gene and protein expression levels via a cAMP/PKA dependent pathway in cementoblasts. Bone 47: 564–572.